BioCentury | Apr 7, 2014
Company News

NovaDel neurology news

...the discretion of the undisclosed third party. The company said ZolpiMist revenues are not disclosed. Rechon Life Science AB...
BioCentury | Aug 29, 2011
Company News

NovaDel, Rechon sales and marketing update

...NovaDel granted Rechon an exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the...
...exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the U.S. and Canada. Rechon...
...Canada. Terms were not disclosed (see BioCentury, Feb. 14). NovaDel Pharma Inc. (OTCBB:NVDL), Bridgewater, N.J. Rechon Life Science AB...
Items per page:
1 - 2 of 2
BioCentury | Apr 7, 2014
Company News

NovaDel neurology news

...the discretion of the undisclosed third party. The company said ZolpiMist revenues are not disclosed. Rechon Life Science AB...
BioCentury | Aug 29, 2011
Company News

NovaDel, Rechon sales and marketing update

...NovaDel granted Rechon an exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the...
...exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the U.S. and Canada. Rechon...
...Canada. Terms were not disclosed (see BioCentury, Feb. 14). NovaDel Pharma Inc. (OTCBB:NVDL), Bridgewater, N.J. Rechon Life Science AB...
Items per page:
1 - 2 of 2